JP2009516517A5 - - Google Patents

Download PDF

Info

Publication number
JP2009516517A5
JP2009516517A5 JP2008541541A JP2008541541A JP2009516517A5 JP 2009516517 A5 JP2009516517 A5 JP 2009516517A5 JP 2008541541 A JP2008541541 A JP 2008541541A JP 2008541541 A JP2008541541 A JP 2008541541A JP 2009516517 A5 JP2009516517 A5 JP 2009516517A5
Authority
JP
Japan
Prior art keywords
rna molecules
specificity
manufactured
done
sequences present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008541541A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009516517A (ja
JP5078904B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2006/001741 external-priority patent/WO2007056826A1/en
Publication of JP2009516517A publication Critical patent/JP2009516517A/ja
Publication of JP2009516517A5 publication Critical patent/JP2009516517A5/ja
Application granted granted Critical
Publication of JP5078904B2 publication Critical patent/JP5078904B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008541541A 2005-11-21 2006-11-21 多標的干渉ｒｎａならびにそれらの使用および設計方法 Expired - Fee Related JP5078904B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73844105P 2005-11-21 2005-11-21
US73864005P 2005-11-21 2005-11-21
US60/738,640 2005-11-21
US60/738,441 2005-11-21
PCT/AU2006/001741 WO2007056826A1 (en) 2005-11-21 2006-11-21 Multitargeting interfering rnas and methods of their use and design

Publications (3)

Publication Number Publication Date
JP2009516517A JP2009516517A (ja) 2009-04-23
JP2009516517A5 true JP2009516517A5 (enExample) 2012-07-26
JP5078904B2 JP5078904B2 (ja) 2012-11-21

Family

ID=38048226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008541541A Expired - Fee Related JP5078904B2 (ja) 2005-11-21 2006-11-21 多標的干渉ｒｎａならびにそれらの使用および設計方法
JP2008541543A Ceased JP2009516518A (ja) 2005-11-21 2006-11-21 ２種の活性鎖を有する多標的干渉ｒｎａならびにそれらの設計および使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008541543A Ceased JP2009516518A (ja) 2005-11-21 2006-11-21 ２種の活性鎖を有する多標的干渉ｒｎａならびにそれらの設計および使用方法

Country Status (6)

Country Link
US (3) US20070269815A1 (enExample)
EP (2) EP1951263A4 (enExample)
JP (2) JP5078904B2 (enExample)
AU (2) AU2006315102A1 (enExample)
CA (2) CA2630932A1 (enExample)
WO (2) WO2007056829A1 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053019A2 (en) * 2006-11-02 2008-05-08 Dsm Ip Assets B.V. Method for reducing the expression of a gene in a filamentous fungal cell
US20120071539A1 (en) * 2006-12-12 2012-03-22 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2008094516A2 (en) 2007-01-29 2008-08-07 City Of Hope Multi-targeting short interfering rnas
EP2121924A1 (en) * 2007-03-02 2009-11-25 MDRNA, Inc. Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof
US20100112687A1 (en) * 2007-03-02 2010-05-06 Mdrna, Inc. Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
WO2008109105A2 (en) * 2007-03-06 2008-09-12 Flagship Ventures Methods and compositions for improved therapeutic effects with sirna
WO2008137867A2 (en) * 2007-05-03 2008-11-13 Rosetta Inpharmatics Llc Compositions comprising mir34 therapeutic agents for treating cancer
US20100286238A1 (en) * 2007-05-15 2010-11-11 Rivory Laurent Pierre Suppression of viruses involved in respiratory infection or disease
US20100022618A1 (en) 2007-09-05 2010-01-28 Dong Liang Long interfering nucleic acid duplexes targeting multiple RNA targets
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
JP5654352B2 (ja) 2007-11-09 2015-01-14 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム ｍｉＲ−１５ファミリーのマイクロＲＮＡによる心筋細胞生存及び心臓修復の調節
GB2468477A (en) * 2009-03-02 2010-09-15 Mina Therapeutics Ltd Double stranded RNA molecule comprising siRNA and miRNA precursors
AU2010259295B2 (en) 2009-06-10 2015-05-07 Temasek Life Sciences Laboratory Limited Virus induced gene silencing (VIGS) for functional analysis of genes in cotton.
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
US20130023578A1 (en) * 2009-12-31 2013-01-24 Samyang Biopharmaceuticals Corporation siRNA for inhibition of c-Met expression and anticancer composition containing the same
PL2545182T4 (pl) 2010-03-08 2017-11-30 Monsanto Technology Llc Cząsteczki polinukeotydu do regulacji genów w roślinach
AR083445A1 (es) 2010-10-14 2013-02-27 Univ Mie siARN CONTRA LA FIBROSIS
MX377067B (es) 2011-09-13 2025-03-07 Monsanto Technology Llc Métodos y composiciones para el control de malezas.
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
US9580708B2 (en) 2011-09-14 2017-02-28 Rana Therapeutics, Inc. Multimeric oligonucleotides compounds
JP6280045B2 (ja) * 2011-12-22 2018-02-14 アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 肺腺癌内転移関連性転写物１（ｍｅｔａｓｔａｓｉｓ−ａｓｓｏｃｉａｔｅｄ−ｉｎ−ｌｕｎｇ−ａｄｅｎｏｃａｒｃｉｎｏｍａ−ｔｒａｎｓｃｒｉｐｔ−１：ｍａｌａｔ−１）の発現調節法
US9212363B2 (en) * 2012-05-11 2015-12-15 City Of Hope RNAI molecules with non-watson crick pairing based on artificial mutation consensus sequences to counter escape mutations
BR112014028634A2 (pt) 2012-05-16 2017-06-27 Rana Therapeutics Inc composições e métodos para modulação da expressão de utrn
CA2873769A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics Inc. Compositions and methods for modulating hemoglobin gene family expression
BR112014028644A2 (pt) 2012-05-16 2017-08-15 Rana Therapeutics Inc Composições e métodos para modulação da expressão de atp2a2
AU2013262709A1 (en) 2012-05-16 2015-01-22 Rana Therapeutics, Inc. Compositions and methods for modulating MECP2 expression
US10837014B2 (en) 2012-05-16 2020-11-17 Translate Bio Ma, Inc. Compositions and methods for modulating SMN gene family expression
SG11201407483YA (en) 2012-05-16 2014-12-30 Rana Therapeutics Inc Compositions and methods for modulating smn gene family expression
AR091143A1 (es) 2012-05-24 2015-01-14 Seeds Ltd Ab Composiciones y metodos para silenciar la expresion genetica
US9163235B2 (en) 2012-06-21 2015-10-20 MiRagen Therapeutics, Inc. Inhibitors of the miR-15 family of micro-RNAs
EP2895200B1 (en) 2012-09-14 2019-11-06 Translate Bio MA, Inc. Multimeric oligonucleotide compounds
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
KR20150103280A (ko) * 2013-01-08 2015-09-09 베니텍 바이오파마 리미티드 연령-관련 황반 변성 치료
EP2971185A4 (en) 2013-03-13 2017-03-08 Monsanto Technology LLC Methods and compositions for weed control
UA121846C2 (uk) 2013-03-13 2020-08-10 Монсанто Текнолоджи Ллс Спосіб та гербіцидна композиція для контролю видів рослини роду lolium
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
MX359191B (es) 2013-07-19 2018-09-18 Monsanto Technology Llc Composiciones y métodos para controlar leptinotarsa.
WO2015051283A1 (en) 2013-10-04 2015-04-09 Rana Therapeutics, Inc. Compositions and methods for treating amyotrophic lateral sclerosis
UY35817A (es) 2013-11-04 2015-05-29 Us Agriculture ?composiciones y métodos para controlar infestaciones de plagas y parásitos de los artrópodos?.
UA119253C2 (uk) 2013-12-10 2019-05-27 Біолоджикс, Інк. Спосіб боротьби із вірусом у кліща varroa та у бджіл
EP3116303B1 (en) 2014-01-15 2020-07-22 Monsanto Technology LLC Methods and compositions for weed control using epsps polynucleotides
US9856475B2 (en) 2014-03-25 2018-01-02 Arcturus Therapeutics, Inc. Formulations for treating amyloidosis
JP6771387B2 (ja) 2014-03-25 2020-10-21 アークトゥラス・セラピューティクス・インコーポレイテッドＡｒｃｔｕｒｕｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 遺伝子サイレンシング用トランスサイレチン対立遺伝子選択的ｕｎａオリゴマー
CA2946719C (en) * 2014-03-25 2023-09-26 Arcturus Therapeutics, Inc. Una oligomers having reduced off-target effects in gene silencing
EP3420809A1 (en) 2014-04-01 2019-01-02 Monsanto Technology LLC Compositions and methods for controlling insect pests
AU2015280252A1 (en) * 2014-06-23 2017-01-12 Monsanto Technology Llc Compositions and methods for regulating gene expression via RNA interference
WO2015200539A1 (en) 2014-06-25 2015-12-30 Monsanto Technology Llc Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
WO2016018887A1 (en) 2014-07-29 2016-02-04 Monsanto Technology Llc Compositions and methods for controlling insect pests
JP6726105B2 (ja) 2014-12-15 2020-07-22 株式会社ボナック ＴＧＦ−β１発現抑制のための一本鎖核酸分子
PL3256589T3 (pl) 2015-01-22 2022-02-21 Monsanto Technology Llc Kompozycje i sposoby kontrolowania leptinotarsa
US10519447B2 (en) 2015-04-01 2019-12-31 Arcturus Therapeutics, Inc. Therapeutic UNA oligomers and uses thereof
EP3302053B1 (en) 2015-06-02 2021-03-17 Monsanto Technology LLC Compositions and methods for delivery of a polynucleotide into a plant
EP3302030A4 (en) 2015-06-03 2019-04-24 Monsanto Technology LLC METHOD AND COMPOSITIONS FOR INTRODUCING NUCLEIC ACIDS IN PLANTS
WO2017015671A1 (en) 2015-07-23 2017-01-26 Arcturus Therapeutics, Inc. Compositions for treating amyloidosis
WO2017032776A1 (en) * 2015-08-21 2017-03-02 Universitätsklinikum Jena Human micrornas for treatment of malignant tumours
EP3618634A4 (en) * 2017-05-01 2021-07-21 Donald Danforth Plant Science Center RNA-BASED APPROACH TO PLANT PROTECTION
MX2021010152A (es) 2019-02-27 2021-09-14 Ionis Pharmaceuticals Inc Moduladores de la expresion de malat1.
CN117813380A (zh) * 2021-06-23 2024-04-02 维萨梅布有限公司 用于调节诸基因表达的组合物和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050209180A1 (en) * 2001-05-18 2005-09-22 Sirna Therapeutics, Inc. RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)
US20050187174A1 (en) * 2001-05-18 2005-08-25 Sirna Therapeutics, Inc. RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
US20050148530A1 (en) * 2002-02-20 2005-07-07 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
WO2003070912A2 (en) * 2001-06-06 2003-08-28 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US20050048529A1 (en) * 2002-02-20 2005-03-03 Sirna Therapeutics, Inc. RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
AU2004266311B2 (en) * 2001-05-18 2009-07-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
EP1590002A4 (en) * 2003-01-17 2007-02-28 Univ Florida siRNA GENE THERAPY
JP2008511678A (ja) * 2004-09-02 2008-04-17 イェール ユニバーシティ マイクロｒｎａによるオンコジーンの調節

Similar Documents

Publication Publication Date Title
JP2009516517A5 (enExample)
JP2009516518A5 (enExample)
AU2009236219A8 (en) Silencing of CSN5 gene expression using interfering RNA
EP2173872A4 (en) COPY DNA AND SENSE RNA
WO2009111508A3 (en) Metalloproteinase 9 and metalloproteinase 2 binding proteins
WO2009111450A3 (en) Metalloproteinase 9 binding proteins
ATE546526T1 (de) Hybrid-interferenz-rna
EP2162555A4 (en) SPECIFIC AMPLIFICATION OF TUMOR-SPECIFIC DNA SEQUENCES
EP1986697A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING GENERAL INFRINGEMENT BY RNA INTERFERENCE
EA200900404A1 (ru) Новые гены, родственные гену глутаминилциклазы
EP1943348A4 (en) COMPOSITIONS, METHODS AND KITS FOR THE AMPLIFICATION OF NUCLEIC ACIDS
WO2007095316A3 (en) Compositions and methods for oligonucleotide formulations
EP2268813A4 (en) RNA MOLECULES AND USES THEREOF
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
ME02268B (me) POSTUPAK ZA DOBIJANJE MODIFIKOVANIH ELEKTRODA, ELEKTRODE DOBIJENE TIM POSTUPKOM I ENZIMATSKI BIOSENZORl KOJI SADRŽE TE ELEKTRODE
DE602006008827D1 (de) Herbizidresistenz verleihende gene grg23 und grg51
WO2006135684A3 (en) Methods and kits for sense rna synthesis
EP2061797A4 (en) Therapeutic Procedures Using WRN-Binding Molecules
WO2010009478A3 (en) Compositions and methods for treating disorders associated with overweight animals
BRPI0908553A2 (pt) genes e enzimas termofílicos e termoacidofílicos do metabolismo do alicyclobacillus acidocaldarius, organismos relacionados e métodos
EP2226384A4 (en) COMPLEX OF POLYSACCHARIDE AND DOUBLE-STRAND RNA
WO2008030996A3 (en) Sirna and methods of manufacture
IL201445A0 (en) Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
PL2295549T3 (pl) Cząsteczki kwasu nukleinowego Nicotiana i ich zastosowanie
GB0612301D0 (en) DNA molecules and methods